This section provides company information.
MiZ Company Limited has foreseen the possibilities of medical use of molecular hydrogen since the company’s establishment, and has advanced in research and development on the premises that molecular hydrogen should provide a paradigm shift in health and medicine of the 21st Century. We hope to be a world-wide leading presence in hydrogen administration technology for clinical applications.
Trade name | MiZ Company Limited |
---|---|
Foundation | November 25, 1991 |
Capital | 50 million yen |
CEO | Fumitake Sato |
Location | 2-19-15 Ofuna Kamakura, Kanagawa 247-0056, JAPAN |
Phone | +81-467-53-7511 |
FAX | +81-467-53-7510 |
Description of business | Research of molecular hydrogen as a medical treatment gas |